The Journal of Hematopathology aims at providing pathologists with a special interest in hematopathology with information needed to perform high-quality diagnostic pathology of hematopoietic and lymphoid diseases in lymphoid tissues, bone marrow and peripheral blood. To this end the journal publishes reviews, editorials, comments, original papers, guidelines and protocols, papers on ancillary techniques, case reports, and images on all topics within the subspecialty of diagnostic hematopathology.

The journal is a useful reference point for all pathologists with an interest in hematopathology. Molecular biologists involved in the expanding field of molecular diagnostics and research on lymphomas and leukemia benefit from the journal, too. Furthermore, the journal is of major interest for hematologists dealing with patients suffering from lymphomas, leukemias, and other benign and malignant hematopoietic and lymphoid diseases.

The journal maintains an international character among its editors, editorial board and authorship, as the field of hematopathology has considerable geographical variations in incidence of diseases. This is not only locally relevant, but due to globalization, relevant for all those involved in the management of patients with hematolymphoid patients.

Editor-in-Chief
William R. Macon, MD
Mayo Clinic
Rochester, Minnesota

Associate Editors

Nathanael G. Bailey, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Judith A. Ferry, MD, Massachusetts General Hospital, Boston, MA, USA
Leticia Quintanilla-Fend, MD, Institut für Pathologie, Tuebingen, Germany
Fernando A. Soares, MD, PhD, Hospital AC Camargo, São Paulo, Brazil
International Editorial Board

Katsuyuki Aozasa, MD, Osaka University School of Medicine, Osaka, Japan
Olga Balagué, MD, Hospital Clinic of Barcelona, Barcelona, Spain
Noah A. Brown, MD, University of Michigan Medicine, Ann Arbor, MI, USA
Carlos Bueso-Ramos, MD, University of Texas MD Anderson Cancer Center, Houston, USA 
Alexander C. L. Chan, MD, Queen Elizabeth Hospital, Kowloon, Hong Kong
Wah Cheuk, MD, Queen Elizabeth Hospital, Kowloon, Hong Kong
Andrew L. Feldman, MD, Mayo Clinic, Rochester, MN, USA
Daphne de Jong, MD, PhD, A. van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands
Laurence de Leval, MD, PhD, University of Lausanne, Lausanne, Switzerland
Falko Fend, MD, University Hospital Tuebingen, Tuebingen, Germany
John R. Goodlad, MB ChB, MD, Queen Elizabeth University Hospital, Glasgow, Scotland
Robert P. Hasserjian, MD, Massachusetts General Hospital, Boston, MA, USA 
K.M. Hebeda, MD, PhD, UMC St. Radboud, Nijmegen, The Netherlands
Rebecca L. King, MD, Mayo Clinic, Rochester, MN, USA
Wolfram Klapper, MD, University Hospital Schleswig-Holstein, Kiel, Germany
Lorenzo Leoncini, MD, University of Siena, Siena, Italy
Megan S. Lim, MD, PhD, University of Michigan, Ann Arbor, MA, USA
Carmen Lome-Maldonado, MD, Instituto Nacional de Cancerlogia, Mexico City, Mexico
Abner Louissaint, Jr, MD, PhD, Massachusetts General Hospital, Boston, MA, USA
Roberto N. Miranda, MD, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Rodney R. Miles, MD, PhD, University of Utah Health Hospital & Clinics, Salt Lake City, Utah
José Carlos Morais, MD, Universidade Federal do Rio de Janeiro, Niterói, Rio de Janeiro, Brazil
German Ott, MD, Abteilung für klinische Pathologi, Stuttgart, Germany
Frederic I. Preffer, PhD, Massachusetts General Hospital, Boston, USA
Lisa M. Rimsza, MD, Mayo Clinic, Scottsdale, AZ, USA
Adam Seegmiller, MD, PhD, Vanderbilt University, Nashville, TN, USA
Soo Yong Tan, MBBS, National University of Singapore, Singapore 
Jenny Turner, MBBS, Macquarie University, Sydney Australia
Chris van Vliet, MD, PathWest Laboratory Medicine, Nedlands, WA, Australia
José Vassallo, MD, State University of Campinas, Campinas, Brazil
Anahi Vijnovich-Baron, MD, Centro de Patologia y Citologia, Buenos Aires, Argentina